RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Dallas, TX · Houston, TX · Humble, TX · +53 more sites
3 recruiting obesity studies with a site in Humble, TX.
Sponsor: AstraZeneca
Dallas, TX · Houston, TX · Humble, TX · +53 more sites
Sponsor: Amgen
Amarillo, TX · Austin, TX · +137 more sites
Sponsor: Amgen
Amarillo, TX · Austin, TX · Conroe, TX · +118 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.